Steatosis and fibrosis progression in patients with recurrent hepatitis C infection: Complex interactions providing diagnostic and therapeutic challenges-Reference-Cited by-同舟云学术

Steatosis and fibrosis progression in patients with recurrent hepatitis C infection: Complex interactions providing diagnostic and therapeutic challenges

Published:2011-11-29 Issue:12 Volume:17 Page:1374-1379
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Hübscher Stefan G.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference56 articles.

1. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus;Brandman;Liver Transpl,2011

2. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data;Serfaty;Liver Int,2009

3. Steatosis in chronic hepatitis C: why does it really matter?;Asselah;Gut,2006

4. Steatosis and insulin resistance in hepatitis C: a way out for the virus?;Del Campo;World J Gastroenterol,2009

5. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response;Younossi;Liver Int,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lebertransplantation;Pathologie;2020

2. Transplantation Pathology;Macsween's Pathology of the Liver;2018

3. Clinical significance of intragraft miR-122 and -155 expression after liver transplantation;Hepatology Research;2014-11-17

4. Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment;Journal of Hepatology;2013-05

5. Infectious diseases of the hepatobiliary system;Diagnostic Histopathology;2013-03